• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗性利用人体抗体反应的工具。

Tools to therapeutically harness the human antibody response.

机构信息

Department of Medicine/Rheumatology, University of Chicago, Chicago, Illinois 60637, USA.

出版信息

Nat Rev Immunol. 2012 Oct;12(10):709-19. doi: 10.1038/nri3285.

DOI:10.1038/nri3285
PMID:23007571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7097371/
Abstract

The natural human antibody response is a rich source of highly specific, neutralizing and self-tolerant therapeutic reagents. Recent advances have been made in isolating and characterizing monoclonal antibodies that are generated in response to natural infection or vaccination. Studies of the human antibody response have led to the discovery of crucial epitopes that could serve as new targets in vaccine design and in the creation of potentially powerful immunotherapies. With a focus on influenza virus and HIV, herein we summarize the technological tools used to identify and characterize human monoclonal antibodies and describe how these tools might be used to fight infectious diseases.

摘要

自然人类抗体反应是高度特异性、中和性和自身耐受性治疗试剂的丰富来源。最近在分离和表征针对自然感染或接种疫苗产生的单克隆抗体方面取得了进展。对人类抗体反应的研究导致发现了关键表位,这些表位可以作为疫苗设计和潜在强大免疫疗法的新靶点。本文重点介绍流感病毒和 HIV,我们总结了用于鉴定和表征人类单克隆抗体的技术工具,并描述了如何将这些工具用于对抗传染病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/92e9bf43a4c4/41577_2012_Article_BFnri3285_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/a00350a274ef/41577_2012_Article_BFnri3285_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/6c1196aa6abd/41577_2012_Article_BFnri3285_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/92e9bf43a4c4/41577_2012_Article_BFnri3285_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/a00350a274ef/41577_2012_Article_BFnri3285_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/6c1196aa6abd/41577_2012_Article_BFnri3285_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def3/7097371/92e9bf43a4c4/41577_2012_Article_BFnri3285_Fig3_HTML.jpg

相似文献

1
Tools to therapeutically harness the human antibody response.用于治疗性利用人体抗体反应的工具。
Nat Rev Immunol. 2012 Oct;12(10):709-19. doi: 10.1038/nri3285.
2
The human antibody response to dengue virus infection.人类对登革热病毒感染的抗体反应。
Viruses. 2011 Dec;3(12):2374-95. doi: 10.3390/v3122374. Epub 2011 Nov 25.
3
Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans.定量评估戊型肝炎疫苗在人体中诱导的保护性抗体应答。
Nat Commun. 2020 Aug 7;11(1):3971. doi: 10.1038/s41467-020-17737-w.
4
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.绘制人类记忆B细胞和血清中和抗体对登革病毒4型感染及疫苗接种的反应图谱。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.
5
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.
6
Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.人类暴露于高致病性H7N7禽流感病毒后抗体反应的抗原指纹分析:抗PA-X抗体的证据
J Virol. 2016 Sep 29;90(20):9383-93. doi: 10.1128/JVI.01408-16. Print 2016 Oct 15.
7
Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.源自 2009 年大流行 H1N1 流感疫苗接种者记忆 B 细胞的针对甲型流感病毒的全人源广谱中和单克隆抗体。
Virology. 2013 Jan 20;435(2):320-8. doi: 10.1016/j.virol.2012.09.034. Epub 2012 Oct 16.
8
Influenza virus antigenicity and broadly neutralizing epitopes.流感病毒抗原性及广泛中和表位
Curr Opin Virol. 2015 Apr;11:113-21. doi: 10.1016/j.coviro.2015.03.006. Epub 2015 Apr 4.
9
Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches.优化人杂交瘤技术研究人类针对流感病毒的抗体反应的最新进展。
Vaccine. 2009 Dec 30;27 Suppl 6:G47-51. doi: 10.1016/j.vaccine.2009.10.124.
10
Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses.多聚体表位支架 HIV 疫苗靶向 V1V2 并差异化调节多功能抗体反应。
Cell Rep. 2019 Jul 23;28(4):877-895.e6. doi: 10.1016/j.celrep.2019.06.074.

引用本文的文献

1
An iterative strategy to design 4-1BB agonist nanobodies de novo with generative AI models.一种利用生成式人工智能模型从头设计4-1BB激动剂纳米抗体的迭代策略。
Sci Rep. 2025 Jul 14;15(1):25412. doi: 10.1038/s41598-025-10241-5.
2
Utility of binding protein fusions to immunoglobulin heavy chain constant regions from mammalian and avian species.结合蛋白与来自哺乳动物和鸟类物种的免疫球蛋白重链恒定区融合的效用。
J Biol Chem. 2025 Apr;301(4):108324. doi: 10.1016/j.jbc.2025.108324. Epub 2025 Feb 18.
3
De novo protein sequencing of antibodies for identification of neutralizing antibodies in human plasma post SARS-CoV-2 vaccination.

本文引用的文献

1
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.大流行性 H1N1 流感疫苗在人体内诱导出一种有利于广泛交叉反应性记忆 B 细胞的回忆反应。
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9047-52. doi: 10.1073/pnas.1118979109. Epub 2012 May 21.
2
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.人类感染大流行 H1N1 流感病毒和接种疫苗会诱导针对血凝素茎的交叉保护抗体。
Front Immunol. 2012 May 8;3:87. doi: 10.3389/fimmu.2012.00087. eCollection 2012.
3
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.
对抗体进行从头蛋白质测序,以鉴定 SARS-CoV-2 疫苗接种后人体血浆中的中和抗体。
Nat Commun. 2024 Oct 10;15(1):8790. doi: 10.1038/s41467-024-53105-8.
4
Atomically accurate de novo design of antibodies with RFdiffusion.利用RFdiffusion进行抗体的原子精确从头设计。
bioRxiv. 2025 Feb 28:2024.03.14.585103. doi: 10.1101/2024.03.14.585103.
5
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections.新兴虫媒病毒感染治疗性单克隆抗体的研发。
Viruses. 2023 Oct 30;15(11):2177. doi: 10.3390/v15112177.
6
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.鉴定针对甲型流感病毒 M1 和 NP 的非中和性人源单克隆抗体。
J Virol. 2023 Nov 30;97(11):e0164622. doi: 10.1128/jvi.01646-22. Epub 2023 Nov 2.
7
Development and application of classical swine fever virus monoclonal antibodies derived from single B cells.经典猪瘟病毒单克隆抗体的来源的 B 细胞的分离与鉴定。
Vet Res. 2023 Oct 16;54(1):90. doi: 10.1186/s13567-023-01229-y.
8
Generation of a single-cell B cell atlas of antibody repertoires and transcriptomes to identify signatures associated with antigen specificity.生成抗体库和转录组的单细胞B细胞图谱,以识别与抗原特异性相关的特征。
iScience. 2023 Jan 25;26(3):106055. doi: 10.1016/j.isci.2023.106055. eCollection 2023 Mar 17.
9
Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings.B 细胞永生化在疫苗和感染环境中分离抗体和 B 细胞克隆中的应用。
Front Immunol. 2022 Dec 13;13:1087018. doi: 10.3389/fimmu.2022.1087018. eCollection 2022.
10
Bioinformatic Analysis of Natively Paired VH:VL Antibody Repertoires for Antibody Discovery.用于抗体发现的天然配对 VH:VL 抗体库的生物信息学分析。
Methods Mol Biol. 2023;2552:447-463. doi: 10.1007/978-1-0716-2609-2_25.
以 HIV-1 为例的疫苗开发中的 B 细胞系免疫原设计。
Nat Biotechnol. 2012 May 7;30(5):423-33. doi: 10.1038/nbt.2197.
4
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.鉴定与人结合的登革病毒粒子上复杂表位的中和抗体。
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.
5
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.人源单克隆抗体对大流行 1957 年 H2N2 和大流行 1968 年 H3N2 流感病毒。
J Virol. 2012 Jun;86(11):6334-40. doi: 10.1128/JVI.07158-11. Epub 2012 Mar 28.
6
A proteomics approach for the identification and cloning of monoclonal antibodies from serum.一种从血清中鉴定和克隆单克隆抗体的蛋白质组学方法。
Nat Biotechnol. 2012 Mar 25;30(5):447-52. doi: 10.1038/nbt.2167.
7
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.在乳糜泻肠病变中,大量分泌转谷氨酰胺酶 2 特异性 IgA 自身抗体的浆细胞,体细胞高频突变有限。
Nat Med. 2012 Feb 26;18(3):441-5. doi: 10.1038/nm.2656.
8
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.一种人源抗体识别 H5 血凝素的保守表位,广泛中和高致病性禽流感 H5N1 病毒。
J Virol. 2012 Mar;86(6):2978-89. doi: 10.1128/JVI.06665-11. Epub 2012 Jan 11.
9
The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases.人类早期 B 细胞耐受的建立:原发性免疫缺陷病的启示。
Ann N Y Acad Sci. 2011 Dec;1246:1-10. doi: 10.1111/j.1749-6632.2011.06347.x.
10
Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.感染后数十年内,具有增强登革热病毒疾病潜力的循环记忆 B 细胞克隆持续存在。
J Virol. 2012 Mar;86(5):2665-75. doi: 10.1128/JVI.06335-11. Epub 2011 Dec 14.